Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nalini Bora

Concepts (239)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uveitis, Anterior
10
2019
28
3.260
 Why?
Autoimmune Diseases
11
2019
101
3.200
 Why?
Choroidal Neovascularization
17
2022
54
3.190
 Why?
Complement System Proteins
7
2014
45
1.940
 Why?
Macular Degeneration
10
2016
46
1.910
 Why?
Disease Models, Animal
22
2022
1448
1.790
 Why?
Autoantigens
5
2009
60
1.260
 Why?
Complement Activation
8
2010
40
1.250
 Why?
Uveitis
5
2009
29
1.070
 Why?
Rats, Inbred Lew
13
2019
69
1.070
 Why?
Immune Tolerance
6
2009
95
1.040
 Why?
Animals
41
2022
13133
0.910
 Why?
Transforming Growth Factor beta2
5
2019
17
0.860
 Why?
Rats
16
2019
3293
0.770
 Why?
Choroid
5
2012
24
0.700
 Why?
Geographic Atrophy
2
2016
7
0.660
 Why?
Complement Pathway, Alternative
2
2011
8
0.650
 Why?
Complement Factor B
2
2011
10
0.650
 Why?
Antigens, Surface
3
2010
54
0.640
 Why?
T-Lymphocytes, Regulatory
2
2009
86
0.640
 Why?
Eye Diseases
3
2008
38
0.630
 Why?
Recombinant Proteins
4
2019
488
0.610
 Why?
CD4-Positive T-Lymphocytes
2
2011
159
0.600
 Why?
Adiponectin
6
2022
64
0.590
 Why?
Complement Membrane Attack Complex
6
2011
19
0.570
 Why?
Eye
4
2006
31
0.570
 Why?
Collagen Type I
2
2009
87
0.550
 Why?
Antigens, Neoplasm
2
2008
151
0.490
 Why?
Reverse Transcriptase Polymerase Chain Reaction
8
2014
594
0.490
 Why?
Neovascularization, Pathologic
3
2012
158
0.480
 Why?
Lasers
8
2011
123
0.470
 Why?
Ethanol
3
2008
342
0.470
 Why?
Blotting, Western
6
2016
600
0.450
 Why?
Complement C4
2
2011
9
0.440
 Why?
Interleukin-2 Receptor alpha Subunit
2
2009
9
0.430
 Why?
Mice
16
2022
5671
0.410
 Why?
Male
25
2020
25439
0.410
 Why?
Receptors, Cell Surface
2
2010
123
0.400
 Why?
Honey
1
2011
8
0.390
 Why?
Keratitis
1
2011
12
0.390
 Why?
Adoptive Transfer
5
2011
40
0.380
 Why?
Pseudomonas Infections
1
2011
49
0.380
 Why?
Eye Injuries
1
2011
27
0.380
 Why?
Wound Healing
2
2016
204
0.370
 Why?
Eye Infections, Bacterial
1
2011
32
0.370
 Why?
Models, Biological
1
2014
722
0.370
 Why?
Vascular Endothelial Growth Factor A
8
2016
201
0.370
 Why?
Down-Regulation
3
2007
347
0.370
 Why?
Complement C3
4
2014
23
0.370
 Why?
Mice, Inbred C57BL
11
2020
1795
0.370
 Why?
Complement Factor H
2
2010
10
0.360
 Why?
Cell Proliferation
6
2020
999
0.360
 Why?
Protein Processing, Post-Translational
2
2009
159
0.360
 Why?
Apoptosis
5
2014
1102
0.350
 Why?
Enzyme-Linked Immunosorbent Assay
5
2016
244
0.350
 Why?
Mice, Knockout
5
2016
842
0.340
 Why?
Epitopes
1
2009
60
0.340
 Why?
Complement Inactivator Proteins
2
2006
5
0.330
 Why?
Immunohistochemistry
5
2014
983
0.310
 Why?
Wet Macular Degeneration
2
2022
12
0.310
 Why?
Cattle
4
2009
216
0.300
 Why?
Acyltransferases
2
2006
29
0.300
 Why?
Complement C3b
2
2006
7
0.280
 Why?
Retinal Pigment Epithelium
3
2016
17
0.280
 Why?
Esters
1
2006
20
0.270
 Why?
Immunity, Innate
1
2007
106
0.260
 Why?
Angiogenesis Inhibitors
2
2020
187
0.250
 Why?
Fatty Acids
1
2006
145
0.250
 Why?
Lipoxygenase Inhibitors
1
2005
6
0.250
 Why?
Prostaglandin-Endoperoxide Synthases
1
2005
26
0.250
 Why?
Cyclooxygenase Inhibitors
1
2005
39
0.250
 Why?
Nitric Oxide Synthase
1
2005
75
0.240
 Why?
Antigens, CD
2
2003
218
0.240
 Why?
Immunologic Factors
1
2006
113
0.240
 Why?
Carboxylic Ester Hydrolases
1
2003
7
0.230
 Why?
Injections, Intravenous
3
2009
141
0.230
 Why?
Mutagenesis, Site-Directed
1
2003
98
0.230
 Why?
Avian Proteins
1
2003
4
0.220
 Why?
Antigen-Presenting Cells
1
2003
26
0.210
 Why?
Blood Proteins
1
2003
80
0.210
 Why?
Polyethylene Glycols
2
2014
89
0.200
 Why?
Cytokines
3
2011
612
0.200
 Why?
Injections, Intraocular
2
2019
6
0.190
 Why?
Myocardium
1
2003
439
0.180
 Why?
Trabeculectomy
1
2020
10
0.180
 Why?
Butyric Acid
1
2020
10
0.180
 Why?
Acetamides
1
2020
20
0.180
 Why?
Glaucoma
1
2020
33
0.180
 Why?
Transforming Growth Factor beta
3
2006
142
0.170
 Why?
Peptide Fragments
2
2012
210
0.170
 Why?
Endotoxins
2
2011
34
0.170
 Why?
Nicotine
2
2012
186
0.160
 Why?
Melanins
2
2011
27
0.160
 Why?
Specific Pathogen-Free Organisms
2
2009
18
0.160
 Why?
Immunoglobulin G
2
2011
188
0.150
 Why?
Thalidomide
1
2020
377
0.150
 Why?
RNA, Small Interfering
3
2010
215
0.150
 Why?
Pigment Epithelium of Eye
2
2010
8
0.150
 Why?
Humans
16
2022
49863
0.140
 Why?
Lymph Nodes
2
2009
261
0.140
 Why?
Gene Expression Regulation
3
2014
972
0.140
 Why?
T-Lymphocytes
1
2019
330
0.140
 Why?
Retinal Degeneration
1
2016
12
0.130
 Why?
Alcohol Drinking
2
2008
226
0.130
 Why?
Chemokine CCL2
2
2016
71
0.130
 Why?
RNA, Messenger
3
2010
1101
0.130
 Why?
Amino Acid Sequence
3
2009
582
0.120
 Why?
Aspirin
1
2016
113
0.120
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2016
124
0.120
 Why?
Photoreceptor Cells, Vertebrate
1
2014
3
0.120
 Why?
Peptides
2
2022
224
0.110
 Why?
Follow-Up Studies
2
2011
2174
0.110
 Why?
In Situ Nick-End Labeling
2
2014
57
0.100
 Why?
Molecular Sequence Data
2
2004
791
0.100
 Why?
Vascular Endothelial Growth Factors
1
2012
15
0.100
 Why?
Receptors, Adiponectin
3
2022
10
0.100
 Why?
Membrane Glycoproteins
2
2003
247
0.100
 Why?
Proliferating Cell Nuclear Antigen
3
2022
74
0.100
 Why?
Administration, Topical
1
2011
56
0.100
 Why?
Cornea
1
2011
52
0.090
 Why?
Pseudomonas aeruginosa
1
2011
73
0.090
 Why?
Lipoproteins, LDL
1
2012
170
0.090
 Why?
Endothelium, Vascular
1
2012
253
0.090
 Why?
Drug Carriers
1
2011
71
0.090
 Why?
Fluorescent Antibody Technique
1
2010
114
0.090
 Why?
RNA
1
2011
167
0.090
 Why?
Antibodies, Monoclonal, Humanized
1
2012
225
0.090
 Why?
Autoantibodies
1
2011
116
0.090
 Why?
Microscopy, Confocal
3
2005
88
0.090
 Why?
Lymphocyte Depletion
1
2009
8
0.090
 Why?
Immunization
1
2009
65
0.080
 Why?
Cell Membrane
1
2010
251
0.080
 Why?
Forkhead Transcription Factors
1
2009
112
0.080
 Why?
Lymphocyte Count
1
2008
22
0.080
 Why?
Interleukin-2
1
2008
72
0.080
 Why?
Coculture Techniques
1
2008
145
0.080
 Why?
Treatment Outcome
2
2011
5165
0.080
 Why?
Caspase 8
1
2007
12
0.080
 Why?
Caspase 9
1
2007
15
0.080
 Why?
Cell Line
3
2020
1012
0.070
 Why?
Diet
2
2016
555
0.070
 Why?
Cytochromes c
1
2007
30
0.070
 Why?
bcl-2-Associated X Protein
1
2007
55
0.070
 Why?
Caspase 3
1
2007
96
0.070
 Why?
Growth Substances
1
2007
23
0.070
 Why?
Anterior Chamber
1
2007
8
0.070
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2007
129
0.070
 Why?
Complement C5
1
2006
3
0.070
 Why?
Complement C1q
1
2006
8
0.070
 Why?
Receptors, Complement
1
2006
3
0.070
 Why?
Complement C3-C5 Convertases
1
2006
3
0.070
 Why?
Oligodeoxyribonucleotides, Antisense
1
2006
4
0.070
 Why?
Antibodies, Blocking
1
2006
8
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2007
103
0.070
 Why?
Cyclin E
1
2006
6
0.070
 Why?
Cyclin-Dependent Kinase 2
1
2006
16
0.070
 Why?
Macrophage-1 Antigen
1
2006
8
0.070
 Why?
Fluorescent Antibody Technique, Indirect
1
2006
21
0.070
 Why?
Inflammation
1
2010
602
0.070
 Why?
Recombinant Fusion Proteins
1
2007
185
0.070
 Why?
Risk Factors
1
2014
3597
0.070
 Why?
Models, Molecular
1
2007
336
0.070
 Why?
Chemokines
1
2006
78
0.060
 Why?
Cell Adhesion Molecules
1
2006
89
0.060
 Why?
Collagen
1
2007
209
0.060
 Why?
Arachidonate 5-Lipoxygenase
1
2005
4
0.060
 Why?
Cyclooxygenase 2 Inhibitors
1
2005
19
0.060
 Why?
Guanidines
1
2005
31
0.060
 Why?
Injections, Subcutaneous
1
2005
53
0.060
 Why?
Nitric Oxide Synthase Type II
1
2005
66
0.060
 Why?
Cyclooxygenase 2
1
2005
45
0.060
 Why?
Flow Cytometry
1
2007
473
0.060
 Why?
Macrophages
1
2007
364
0.060
 Why?
Fibroblast Growth Factors
1
2005
47
0.060
 Why?
Up-Regulation
1
2006
448
0.060
 Why?
Immune Sera
1
2004
17
0.060
 Why?
Organ Specificity
1
2004
107
0.060
 Why?
Sequence Homology
1
2003
19
0.060
 Why?
Pyrazoles
1
2005
114
0.060
 Why?
Sulfonamides
1
2005
127
0.060
 Why?
COS Cells
1
2003
74
0.060
 Why?
Bruch Membrane
1
2003
1
0.060
 Why?
Enzyme Activation
1
2003
273
0.050
 Why?
Hypersensitivity, Delayed
1
2003
21
0.050
 Why?
Disease Progression
1
2006
822
0.050
 Why?
Interleukin-12
1
2003
31
0.050
 Why?
Fluorescein-5-isothiocyanate
1
2022
9
0.050
 Why?
Ophthalmic Solutions
1
2022
19
0.050
 Why?
Structure-Activity Relationship
1
2003
396
0.050
 Why?
Interleukin-10
1
2003
85
0.050
 Why?
Antibodies, Monoclonal
1
2006
459
0.050
 Why?
Cells, Cultured
3
2012
1579
0.050
 Why?
Antibodies, Neutralizing
2
2012
65
0.050
 Why?
Time Factors
3
2014
2889
0.050
 Why?
Tetrazolium Salts
1
2020
14
0.050
 Why?
Immunotherapy
1
2003
237
0.050
 Why?
Rats, Inbred BN
2
2012
17
0.050
 Why?
Mitomycin
1
2020
20
0.050
 Why?
Lidocaine
1
2020
49
0.040
 Why?
Human Umbilical Vein Endothelial Cells
1
2020
92
0.040
 Why?
Aging
1
2004
669
0.040
 Why?
Endothelial Cells
2
2012
260
0.040
 Why?
Mutation
1
2003
1290
0.040
 Why?
Immunoenzyme Techniques
2
2010
144
0.040
 Why?
Female
1
2016
26520
0.030
 Why?
Complement C1 Inhibitor Protein
1
2014
2
0.030
 Why?
Aminopeptidases
1
2014
17
0.030
 Why?
Matrix Metalloproteinase 9
1
2014
89
0.030
 Why?
Serine Endopeptidases
1
2014
53
0.030
 Why?
Autophagy
1
2014
167
0.030
 Why?
Bungarotoxins
1
2012
6
0.030
 Why?
Intravitreal Injections
1
2012
35
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
32
0.030
 Why?
Aged
2
2022
9434
0.030
 Why?
Receptors, Nicotinic
1
2012
76
0.020
 Why?
Oxidation-Reduction
1
2012
319
0.020
 Why?
Complement C9
1
2011
3
0.020
 Why?
Polymerase Chain Reaction
1
2012
453
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
410
0.020
 Why?
Analysis of Variance
1
2012
553
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1354
0.020
 Why?
Vision, Ocular
1
2010
11
0.020
 Why?
Transcriptome
1
2012
313
0.020
 Why?
Gene Expression
1
2012
613
0.020
 Why?
Protein Structure, Tertiary
1
2009
251
0.020
 Why?
Models, Animal
1
2009
229
0.020
 Why?
Immune System
1
2004
44
0.010
 Why?
Immunoblotting
1
2003
117
0.010
 Why?
Thromboplastin
1
2003
6
0.010
 Why?
Gene Library
1
2003
43
0.010
 Why?
Cell Adhesion
1
2003
157
0.010
 Why?
Adenoviridae
1
2003
51
0.010
 Why?
DNA, Complementary
1
2003
135
0.010
 Why?
Genetic Vectors
1
2003
127
0.010
 Why?
Retina
1
2003
65
0.010
 Why?
Swine
1
2003
398
0.010
 Why?
Protein Binding
1
2003
653
0.010
 Why?
Liver
1
2003
1110
0.010
 Why?
Middle Aged
1
2003
12258
0.000
 Why?
Bora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (239) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department